Featured Research

from universities, journals, and other organizations

Closer to finding treament for Duchenne muscular dystrophy

Date:
December 1, 2011
Source:
University of Royal Holloway London
Summary:
Academics have made an important breakthrough in the development of a treatment for Duchenne muscular dystrophy (DMD).

Dystrophin protein in a human muscle cell.
Credit: Image courtesy of University of Royal Holloway London

Academics from Royal Holloway, University of London and a team lead by scientists at the UCL Institute of Child Health (ICH), have made an important breakthrough in the development of a treatment for Duchenne muscular dystrophy (DMD) which in the future could help the likes of the Lloyd family who were featured on a recent X-Factor T.V. show in the U.K.

Related Articles


The family's story was shown before the X Factor stars performed the show's charity song in aid of sick children. In a moving interview the boys' parents Helen and Chris Lloyd spoke about when their identical twins Dan and Sam, 16, were first diagnosed with the genetic disease DMD when they started showing signs of struggling to move.

But the family's ordeal got worse when younger brother Tom, 13, was also diagnosed with the life-limiting condition that affects one in 3,000 male births in the general population, with around 100 cases diagnosed in the UK each year.

Together with the MDEX Consortium, Professor George Dickson from the School of Biological Sciences at Royal Holloway showed that a gene-based drug treatment was effective in restoring the dystrophin protein that is missing in sufferers of DMD, in seven out of 19 trial participants.

DMD causes progressive muscle weakness due to the breakdown and loss of muscle cells. Patients lack a single important protein in their muscle fibres called dystrophin. By the ages of eight to 12, boys become unable to walk and by their late teens or early twenties the condition can become severe enough to limit life expectancy.

In this clinical trial of 19 patients, study participants aged five to 15 at Great Ormond Street Hospital and the Royal Victoria Infirmary, Newcastle, were given weekly doses of the drug, AVI-4658. The drug had already been tested for safety and efficacy by the MDEX Consortium and AVI Biopharma in an earlier phase of the study (Kinali et al, Lancet Neurol 2009).

Professor Dickson said: "Duchenne dystrophy is a very serious inherited disorder which affects 1 in 3,000 boys from age four onwards so to have all three brothers affected by the disease is very rare indeed. It is a progressive and severe muscle wasting disease which is currently untreatable. But our ongoing clinical trials have great promise as a long-term treatment and we hope in future to be able to help transform the lives of families like the Lloyds who have to go through this terrible ordeal."


Story Source:

The above story is based on materials provided by University of Royal Holloway London. Note: Materials may be edited for content and length.


Cite This Page:

University of Royal Holloway London. "Closer to finding treament for Duchenne muscular dystrophy." ScienceDaily. ScienceDaily, 1 December 2011. <www.sciencedaily.com/releases/2011/11/111128121356.htm>.
University of Royal Holloway London. (2011, December 1). Closer to finding treament for Duchenne muscular dystrophy. ScienceDaily. Retrieved April 21, 2015 from www.sciencedaily.com/releases/2011/11/111128121356.htm
University of Royal Holloway London. "Closer to finding treament for Duchenne muscular dystrophy." ScienceDaily. www.sciencedaily.com/releases/2011/11/111128121356.htm (accessed April 21, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, April 21, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Blue Bell Recalls All Products

Blue Bell Recalls All Products

AP (Apr. 21, 2015) Blue Bell Creameries voluntary recalled for all of its products after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria. Blue Bell&apos;s President and CEO issued a video statement. (April 21) Video provided by AP
Powered by NewsLook.com
'Tutu Tuesdays' Brighten Faces at Kids' Hospital

'Tutu Tuesdays' Brighten Faces at Kids' Hospital

AP (Apr. 21, 2015) Doctors and nurses have started wearing ballet tutus every Tuesday to cheer up young hospital patients at a Florida hospital. It started with a request made by a nervous patient -- now, almost the entire staff is wearing the tutus. (April 21) Video provided by AP
Powered by NewsLook.com
Humanoid Robot Can Recognise and Interact With People

Humanoid Robot Can Recognise and Interact With People

Reuters - Innovations Video Online (Apr. 20, 2015) An ultra-realistic humanoid robot called &apos;Han&apos; recognises and interprets people&apos;s facial expressions and can even hold simple conversations. Developers Hanson Robotics hope androids like Han could have uses in hospitality and health care industries where face-to-face communication is vital. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Labour Party Warns Britain's Health Service 'on Life Support'

Labour Party Warns Britain's Health Service 'on Life Support'

AFP (Apr. 20, 2015) Britain&apos;s opposition Labour Party Monday claimed the National Health Service (NHS) was &apos;on life support&apos; as it turned its attention to the state-run service, which is a key issue for the UK&apos;s May 7 general election. Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins